15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering PolyPid, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $9.00 to $13.00, a moderate spread. The average target of $11.67 sits 195% above the current $3.95. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.30 next quarter toward $-1.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to PolyPid.
As of Jul, 3 of 3 firms rate PYPD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PYPD EPS & revenue forecast
EPS · NEXT QUARTER
$0.30
Range $-0.40 – $1.02 · 4 analysts · -182% YoY
Next period, 4 analysts expect PolyPid to earn $0.30 a share (range $-0.40 – $1.02), versus $-0.37 a year earlier. Full-year consensus is $-0.85, growing to $-1.11 the year after.
REVENUE · NEXT QUARTER
$15.0M
Range $0 – $30.0M · 4 analysts
Revenue is expected to reach $15.0M (range $0 – $30.0M). Full-year consensus is $15.0M, rising to $8.6M next year.
Top analysts covering PolyPid
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PYPD.
#1
Chase Knickerbocker
Craig-Hallum · Rank #25
Buy
$13.00+229.1% to target
Overall win rate
58%
+ Follow
#2
Roy Buchanan
JMP Securities · Rank #109
Buy
$14.00+254.4% to target
Overall win rate
48%
+ Follow
#3
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Buy
$11.00+178.5% to target
Overall win rate
37%
+ Follow
#4
BF
Brandon Folkes
HC Wainwright & Co.
Buy
$13.00+229.1% to target
Coverage
—
+ Follow
#5
Boobalan Pachaiyappan
Roth Capital
Buy
$9.00+127.8% to target
Coverage
—
+ Follow
PYPD stock forecast FAQ
What is PYPD's average 12-month price target?+
The 3 analysts with a live target average $11.67 for PolyPid over the next 12 months, ranging from a $13.00 high to a $9.00 low.
Is PYPD stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PYPD?+
The Street-high target is $13.00 (HC Wainwright & Co.), and the Street-low is $9.00 (Roth Capital). The average of all 3 active targets is $11.67.
How many Wall Street analysts cover PYPD?+
3 analysts have an active rating on PolyPid, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering PYPD?+
Among analysts who currently cover PYPD, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #25). Their current call is Buy with a $13.00 target.
What is PolyPid's projected EPS for next quarter?+
The consensus estimate is $0.30 per share (range $-0.40 – $1.02) across 4 analysts. Full-year EPS is projected at $-0.85, rising to $-1.11 the following year.
How much revenue is PolyPid expected to report next quarter?+
Consensus revenue is $15.0M (range $0 – $30.0M). Full-year revenue is projected at $15.0M, growing to $8.6M next year.
Have analysts been upgrading or downgrading PYPD lately?+
As of Jul, 3 of 3 firms rate PYPD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PYPD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
